Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3276681
Max Phase: Preclinical
Molecular Formula: C11H20ClN
Molecular Weight: 165.28
Molecule Type: Small molecule
Associated Items:
ID: ALA3276681
Max Phase: Preclinical
Molecular Formula: C11H20ClN
Molecular Weight: 165.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NC12CCCC3CC(CCC31)C2
Standard InChI: InChI=1S/C11H19N.ClH/c12-11-5-1-2-9-6-8(7-11)3-4-10(9)11;/h8-10H,1-7,12H2;1H
Standard InChI Key: UVQKIHOMYIORES-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 165.28 | Molecular Weight (Monoisotopic): 165.1517 | AlogP: 2.30 | #Rotatable Bonds: 0 |
Polar Surface Area: 26.02 | Molecular Species: BASE | HBA: 1 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.77 | CX LogP: 1.99 | CX LogD: -0.88 |
Aromatic Rings: 0 | Heavy Atoms: 12 | QED Weighted: 0.59 | Np Likeness Score: 1.50 |
1. Aigami K, Inamoto Y, Takaishi N, Fujikura Y.. (1976) Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives., 19 (4): [PMID:1263206] [10.1021/jm00226a018] |
Source(1):